The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer

Author：                                  

Publisher： Science Publishers

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.3, Iss.3, 2015-01, pp. : 563-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin G2: A novel independent prognostic marker in pancreatic cancer

By                                        

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 2986-2990

Spandidos Publications

Access to resources Recommend Favorite

Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells

By            

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 1933-1942

Spandidos Publications

Access to resources Recommend Favorite

High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer

By Zhang Hongtuan   Qi Can   Wang Andi   Li Liang   Xu Yong  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2025-2028

Springer Publishing Company

Access to resources Recommend Favorite

Pantoprazole inhibits human gastric adenocarcinoma SGC-7901 cells by downregulating the expression of pyruvate kinase M2

By        

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 717-722

Spandidos Publications

Access to resources Recommend Favorite

HER2 as a prognostic and predictive marker for breast cancer

By Cooke T.   Reeves J.   Lanigan A.   Stanton P.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 23-28

Springer Publishing Company

Access to resources Recommend Favorite